This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Askat Inc., Mitsubishi Tanabe Pharma Corporation, Other. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014-2018
Title: Innovations by Inventor Hideaki Hara
Introduction
Hideaki Hara is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of ophthalmology through his innovative inventions. With a total of 3 patents, Hara's work focuses on developing novel medicaments for treating ocular diseases.
Latest Patents
Hara's latest patents include an agent for preventing and/or treating ophthalmologic diseases. This invention aims to provide a medicament that addresses ocular angiogenesis, utilizing a pyrazolone derivative as an active ingredient. Another significant patent is a therapeutic agent for ocular disease, which offers a pharmaceutical composition for preventing or treating conditions such as retinochoroidal degeneration.
Career Highlights
Throughout his career, Hideaki Hara has worked with prominent companies, including Mitsubishi Tanabe Pharma Corporation and Askat Inc. His experience in these organizations has contributed to his expertise in developing effective treatments for ocular diseases.
Collaborations
Hara has collaborated with notable coworkers, including Masamitsu Shimazawa and Tomomi Masuda. These partnerships have likely enhanced his research and development efforts in the field of ophthalmology.
Conclusion
Hideaki Hara's contributions to ophthalmology through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the treatment of ocular diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile